A concise method for the preparation of peptide and arginine-rich peptide-conjugated antisense oligonucleotide

Bioconjugate Chemistry

Volumn 14, Issue 3, 2003, Pages 532-538

  Chen, Chang Po ^a   Zhang, Liang Ren ^a   Peng, Yue Feng ^b   Wang, Xiao Bo ^c   Wang, Sheng Qi ^c   Zhang, Li He ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

^c BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYTOLOGY; OLIGONUCLEOTIDES; PRECIPITATION (CHEMICAL); RESINS;

3-HYDROXYPROPIONIC ACID; ANION EXCHANGE RESINS; ANTISENSE OLIGONUCLEOTIDES; COUPLING REACTION; MIMETICS; OLIGONUCLEOTIDE CONJUGATES; SIGNAL PEPTIDE; SYNTHESISED;

PEPTIDES;

2,2 DIMETHYL 3 HYDROXYPROPIONIC ACID; ANION EXCHANGE RESIN; ANTISENSE OLIGONUCLEOTIDE; ARGININE; PEPTIDE; PROPIONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANION EXCHANGE; ARTICLE; CELL MEMBRANE PERMEABILITY; CONJUGATION; ELECTRICITY; HUMAN; HUMAN CELL; PRECIPITATION; SYNTHESIS;

EID: 0038585167     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc034004f     Document Type: Article

References (30)

1. Tamm, I., Dorken, B., and Hartmann, G. (2001) Antisense therapy in oncology: new hope for an old idea? Lancet 358, 489-497.
2. Dean, N. M. (2001) Functional genomics and target validation approaches using antisense oligonucleotide technology. Curr. Opin. Biotech. 12, 622-625.
3. Garcia-Chaumont, C., Seksek, O., Grzybowska, J., Borowske, E., and Bolard, J. (2000) Delivery systems for antisense oligonucleotides. J. Pharm. Ther. 87, 255-277.
4. Allinquant, B., Hantraye, P., Mailleux, P., Moya, K., Bouillot, C., and Prochiantz, A. (1995) Down regulation of amyloid procursor protein inhibits neurite outgrowth in vitro. J. Cell Biol. 128, 919-927.
5. Vives, E., and Lebleu, B. (1997) Selective Coupling of a Highly Basic Peptide to an oligonucleotide. Tetrahedron Lett. 38, 1183-1186.
6. Bongartz, J. P., Aubertin, A. M., Milhaud, P. G., and Lebleu, B. (1994) Improved bioactivity of antisense oligonucleotides conjugated to a fusogenic peptide. Nucleic Acids Res. 22, 4681-4688.
7. Arar, K., Monsigny, M., and Mayer, R. (1993) Synthesis of oligonucleotide-peptide conjugates containing KDEL signal sequence. Tetrahedron Lett. 34, 8087-8090.
8. Chen, C. P., Min, J. M., and Zhang, L. H. (2001) Synthesis and properities of peptide-oligonucleotide conjugates. Prog. Biochem. Biophys. 28, 783-787.
9. Tung, C. H., and Stein, S. (2000) Preparation and applications of peptide-oligonucleotide conjugates. Bioconjugate Chem. 11, 605-618.
10. Waldmann, H., and Gabold, S. (1997) Chemoenzymatic synthesis of nucleopeptide. Chem. Commun. 19, 1861-1862.
11. Chen, C. P., Li, X. X., Zhang, L. R., Min, J. M., Chan, Y. W., Fung, K. P., Wang, S. Q., and Zhang, L. H. (2002) Synthesis of antisense oligonucleotide-peptide conjugate targeting to GLUT1 in HepG-2 and MCF-7 cells. Bioconjugate Chem. 13, 525-529.
12. Vives, E., Bodin, P., and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017.
13. Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pellkey, E. T., Steinman, L., and Rothbard, J. B. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. U.S.A. 97, 13003-13008.
14. Blackburn, E. H. (1991) Structure and function of telomeres. Nature 350, 569-573.
15. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. (1994) Specific association of human telomerase activity with immortal cells and cancers. Science 266, 2011-2015.
16. Norton, J. C., Piatyszek, M. A., Wright, W. E., Shay, J. W., and Corey, D. R. (1996) Inhibition of human telomerase activity by peptide nucleic acids. Nature Biotech. 14, 615-619.
17. Tamura, Y., Tao, M., Miyano-kurosaki, N., Takai, K., and Takaku, H. (2000) Inhibition of human telomerase activity by antisense phosphorothioate oligonucleotides encapsulated with the transfection reagent FuGENE6 in Hela cells. Antisense Nucleic Acid Dev. 10, 87-96.
18. Wang, S. Q., Lin, L., Chen, Z. B., Lin, R. X., Chen, S. H., Guan, W., and Wang, X. H. (2002) In vitro anticancer activity evaluation of antisense oligonucleotide targeting to hEST2 gene of telomerase. Sin. Commun. 47, 378-381.
19. Haralambidis, J., Duncan, L., Angus, K., and Tregear, G. W. (1990) The synthesis of polyamide-oligonucleotide conjugate molecules. Nucleic Acid Res. 18, 493-499.
20. Schwope, I., Bleczinski, C. F., and Richert, C. (1999) Synthesis of 3′,5′-dipeptidyl oligonucleotides. J. Org. Chem. 64, 4749-4761.
21. Alewood, P., Alewood, D., and Miranda, L. (1997) Rapid in situ neutralization protocols for Boc and Fmoc solid-phase chemistries. Methods Enzymol. 289, 15-29.
22. Batenburg, A. M., Demel, R. A., Verkleij, A. J., de Kruiuff, B. (1988) Penetration of the signal sequence of Escherichia coli PhoE protein into phospholipid model membranes leads to lipid-specific changes in signal peptide structure and alterations of lipid organization. Biochemistry 27, 5678-5685.
23. von Heijne, G. (1990) The signal peptide. J. Membr. Biol. 115, 195-201.
24. Gariepy, J., and Kawamura, K. (2001) Vectorial delivery of macromolecules into cells using peptide-based cehicles. Trends Biotechnol. 19, 21-28.
25. Wei, Z., Tung, C. H., Zhu, T., and Stein, S. (1994) Synthesis of oligoarginine-oligonucleotide conjugates and oligoarginine bridged oligonucleotide pairs. Bioconjugate Chem. 5, 468-474.
26. Hughes, J. A., Astriab, A., Yoo, H., Alahari, S., Liang, E., and Juliano, R. L. (1999) In vitro transport and delivery of antisense oligonucleotides. Methods Enzymol. 313, 342-358.
27. Antopolsky, M., Azhayeva, E., Tengvall, U., Auriola, S., Jaaskelainen, I., Ronkko, S., Honkakoski, P., Urtti, A., Lonnberg, H., and Azhayev, A. (1999) Peptide-oligonucleotide phosphorothioate conjugates with membrane translocation and nuclear localization properties. Bioconjugate Chem. 10, 598-606.
28. Astriab-Fisher, A., Sergueev, D., S., Fisher, M., Shaw, B. R., and Juliano R. L. (2000) Antisense inhibition of Pglycoprotein expression using peptide-oliglnucleotide conjugates. Biochem. Pharm. 60, 83-90.
29. Zhu, T., Wei, Z., Tung, C. H., Dickerhof, W. A., Breslauer, K. J., Georgopoulos, D. E., Leibowitz, M. J., and Stein, S. (1993) Oligonucleotide-poly-L-ornithine conjugates: binding to complementry DNA and RNA. Antisense Res. Dev. 3, 265-275.
30. Li, X., X., Zhang, L. R., Lu, J. F., Chen, Y. Z., Min, J. M., and Zhang, L. H. (2003), Signal Peptide Mimics Conjugated to Peptide Nucleic Acid: A Promising Solution for Improving Cell Membrane Premeability. Bioconjugate Chem. 14, 153-157.